Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$35.68 - $44.71 $22,085 - $27,675
-619 Reduced 12.81%
4,212 $0
Q3 2022

Oct 31, 2022

BUY
$42.51 - $54.02 $73,329 - $93,184
1,725 Added 55.54%
4,831 $212,000
Q1 2022

Apr 27, 2022

SELL
$48.09 - $57.79 $13,224 - $15,892
-275 Reduced 8.13%
3,106 $176,000
Q4 2021

Jan 31, 2022

SELL
$47.19 - $62.68 $431,316 - $572,895
-9,140 Reduced 73.0%
3,381 $177,000
Q3 2021

Nov 03, 2021

SELL
$56.91 - $67.81 $100,787 - $120,091
-1,771 Reduced 12.39%
12,521 $749,000
Q2 2021

Jul 30, 2021

BUY
$64.02 - $71.72 $541,481 - $606,607
8,458 Added 144.98%
14,292 $969,000
Q1 2021

Apr 29, 2021

SELL
$53.26 - $68.08 $63,752 - $81,491
-1,197 Reduced 17.02%
5,834 $382,000
Q4 2020

Jan 28, 2021

SELL
$43.41 - $56.51 $22,790 - $29,667
-525 Reduced 6.95%
7,031 $396,000
Q3 2020

Oct 29, 2020

SELL
$47.43 - $60.75 $205,703 - $263,472
-4,337 Reduced 36.47%
7,556 $367,000
Q2 2020

Jul 24, 2020

SELL
$43.51 - $66.59 $51,080 - $78,176
-1,174 Reduced 8.98%
11,893 $662,000
Q1 2020

Apr 29, 2020

BUY
$32.82 - $81.13 $246,806 - $610,097
7,520 Added 135.57%
13,067 $662,000
Q4 2019

Jan 27, 2020

SELL
$60.96 - $77.7 $46,451 - $59,207
-762 Reduced 12.08%
5,547 $429,000
Q3 2019

Oct 28, 2019

BUY
$55.78 - $68.08 $60,577 - $73,934
1,086 Added 20.79%
6,309 $400,000
Q2 2019

Jul 30, 2019

SELL
$53.69 - $65.47 $439,882 - $536,395
-8,193 Reduced 61.07%
5,223 $306,000
Q1 2019

Apr 30, 2019

BUY
$44.53 - $58.9 $384,872 - $509,072
8,643 Added 181.08%
13,416 $762,000
Q4 2018

Feb 01, 2019

SELL
$47.64 - $71.26 $6,050 - $9,050
-127 Reduced 2.59%
4,773 $237,000
Q3 2018

Nov 05, 2018

BUY
$52.03 - $71.41 $254,947 - $349,909
4,900 New
4,900 $348,000
Q4 2017

Jan 31, 2018

SELL
$50.58 - $60.79 $374,241 - $449,785
-7,399 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$53.54 - $68.0 $396,142 - $503,132
7,399
7,399 $410,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.